Literature DB >> 7305980

Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase and of acyl-CoA--cholesterol acyltransferase by the transfer of non-esterified cholesterol to rat liver microsomal vesicles.

K A Mitropoulos, S Venkatesan, B E Reeves, S Balasubramaniam.   

Abstract

The incubation of rat liver microsomal fraction with a serum preparation followed by the re-isolation of the microsomal membranes has resulted in an increase in the concentration of non-esterified cholesterol, a considerable decrease in the activity of 3-hydroxy-3-methylglutaryl-CoA reductase and in an increase in the activity of acyl-CoA-cholesterol acyltransferase in the treated microsomal preparation. These effects were related to the concentration of serum in the incubation mixture and to the duration of the incubation. The transfer of non-esterified cholesterol was specific in that the content of protein and the total phospholipids were similar in the original microsomal fraction and the serum-treated microsomal preparation. The incubation of the microsomal fraction with lipoprotein-deficient serum or with no serum resulted in both cases in small changes in the non-esterified cholesterol, the esterified cholesterol and the total phospholipid content in the treated preparations compared with these concentrations in the original microsomal fraction, whereas the activity of acyl-CoA-cholesterol acyltransferase and of 3-hydroxy-3-methylglutaryl-CoA reductase was similar in the lipoprotein-deficient-serum-treated and the buffer-treated microsomal preparations. The activity of 3-hydroxy-3-methylglutaryl-CoA reductase was lower and the activity of acyl-CoA-cholesterol acyltransferase was higher in the lipoprotein-deficient-serum-treated and the buffer-treated microsomal preparations as compared with these activities in the original microsomal fraction. However, the serum-treated microsomal preparation had considerably lower activity of 3-hydroxy-3-methylglutaryl-CoA reductase and considerably higher activity of acyl-CoA-cholesterol acyltransferase than these activities in buffer-treated and in lipoprotein-deficient-serum-treated microsomal preparations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7305980      PMCID: PMC1162740          DOI: 10.1042/bj1940265

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Studies on the site of the feedback control of cholesterol synthesis.

Authors:  M D SIPERSTEIN; M J GUEST
Journal:  J Clin Invest       Date:  1960-04       Impact factor: 14.808

2.  Effect of alterations of the specific activity of the intracellular acetyl CoA pool on apparent rates of hepatic cholesterogenesis.

Authors:  J M Dietschy; M S Brown
Journal:  J Lipid Res       Date:  1974-09       Impact factor: 5.922

3.  Fluorescent probe analysis of the lipid architecture of natural and experimental cholesterol-rich membranes.

Authors:  J Vanderkooi; S Fischkoff; B Chance; R A Cooper
Journal:  Biochemistry       Date:  1974-04-09       Impact factor: 3.162

4.  Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells.

Authors:  M Shinitzky; M Inbar
Journal:  J Mol Biol       Date:  1974-01-05       Impact factor: 5.469

5.  The effect of interruption of the enterophecatic circulation of bile acids and of cholesterol feeding on cholesterol 7 alpha-hydroxylase in relation to the diurnal rhythm in its activity.

Authors:  K A Mitropoulos; S Balasubramaniam; N B Myant
Journal:  Biochim Biophys Acta       Date:  1973-12-20

6.  Regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol synthesis.

Authors:  D J Shapiro; V W Rodwell
Journal:  J Biol Chem       Date:  1971-05-25       Impact factor: 5.157

7.  The effect of cholesterol feeding and fasting upon beta-hydroxy-beta-methylglutaryl coenzyme A reductase.

Authors:  T C Linn
Journal:  J Biol Chem       Date:  1967-03-10       Impact factor: 5.157

8.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

9.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

10.  Analytical study of microsomes and isolated subcellular membranes from rat liver. IV. Biochemical, physical, and morphological modifications of microsomal components induced by digitonin, EDTA, and pyrophosphate.

Authors:  A Amar-Costesec; M Wibo; D Thinès-Sempoux; H Beaufay; J Berthet
Journal:  J Cell Biol       Date:  1974-09       Impact factor: 10.539

View more
  5 in total

1.  On the mechanism of the modulation in vitro of acyl-CoA:cholesterol acyltransferase by progesterone.

Authors:  S Synouri-Vrettakou; K A Mitropoulos
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

2.  Effect of ketanserin tartrate on HMG CoA reductase and LDL receptor activity in cultured human skin fibroblasts.

Authors:  M Suzukawa; H Nakamura
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  Regulation and interaction of cholesterol, bile salt and lipoprotein synthesis in liver.

Authors:  C A Barth
Journal:  Klin Wochenschr       Date:  1983-12-01

4.  Homoeostatic control of membrane cholesterol and fatty acid metabolism in the rat liver.

Authors:  M L Garg; J R Sabine
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

5.  Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat.

Authors:  A K Walli; D Seidel
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.